BioSpace News Archive

Deals

Renovia Completes $42.3 Million Series B Financing

Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders

August 21, 2018
·
3 min read
Business

BerGenBio ASA: Results for the Second Quarter and First Half 2018

Encouraging clinical data emerging from several phase II trials with highly selective AXL inhibitor bemcentinib (BGB324)

August 21, 2018
·
6 min read
Drug Development

MC2 Therapeutics Announces Positive Top-line Results from Phase 3 Clinical Trial Comparing MC2-01 Cream to Taclonex® in Adults with Psoriasis

MC2-01 Cream demonstrates statistically significant superiority in both treatment success and patient reported treatment convenience compared to Taclonex® Topical Suspension. Both primary and secondary endpoints were met and a submission of NDA to the FDA is now planned for H1 2019.

August 21, 2018
·
5 min read
Business

NeuroVive Pharmaceutical AB Interim Report January - June 2018

NeuroVive out-licenses targeted LHON therapy to BridgeBio

August 21, 2018
·
2 min read
Genetown

IoT Failures Plague 64% of Users Worldwide, as Cloud Complexity Surges

72% of consumers say it is likely software glitches in some IoT applications will cause serious injuries

August 21, 2018
·
5 min read
Policy

Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform

Funding will help accelerate commercialization of the TruDx® 3000, Akonni’s fully-integrated, sample-to-answer diagnostic system

August 21, 2018
·
4 min read
Business

John ‘Zeke’ Czekanski, Global Commercial Head, Leaves Fishawack

In consultation with John ‘Zeke’ Czekanski, Fishawack has mutually and amicably agreed that he will transition out of the business as we evolve our structure to accommodate the growth of the organization and recent acquisitions.

August 21, 2018
·
2 min read
Pharm Country

Siklos, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in retail pharmacies

Medunik USA announced today that Siklos® (hydroxyurea), an FDA-approved orphan drug, is now available in 100 mg tablets for pharmacies to order.

August 21, 2018
·
6 min read
Business

IAIABC Releases Opioid Policy Inventory

New Report Shows State Efforts to Curb the U.S. Opioid Health Crisis

August 21, 2018
·
2 min read
Pharm Country

Demand for Legal Cannabis Leads to Growing R&D Investments

According to data published by Research and Markets, the North American legal cannabis market value is projected to reach approximately USD 35 Billion by 2023 while registering a strong CAGR of 27.1%.

August 21, 2018
·
13 min read